Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 150 publications
Selection of Breast Biopsy Markers: Effect on Breast Imaging Procedures, Follow-up, and Costs.
Journal: Radiographics : a review publication of the Radiological Society of North America, Inc
Published: August 13, 2026
Knowledge Distillation for Breast US AI: Improving Performance and Practicality.
Journal: Radiology. Artificial intelligence
Published: May 27, 2026
The Effect of Germline Pathogenic Variants in the Upgrade Rate to Breast Cancer Among Patients Diagnosed With Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ on Core Needle Biopsy.
Journal: Clinical breast cancer
Published: May 26, 2026
Erratum: Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.
Journal: JCO precision oncology
Published: May 18, 2026
Call Expectations During the Breast Imaging Fellowship: A Survey of Fellowship Directors.
Journal: Academic radiology
Published: March 10, 2026
Sociodemographic Factors Matter in Screening Mammography.
Journal: Radiology. Imaging cancer
Published: January 02, 2026
Quantitative molecular breast imaging for early prediction of neoadjuvant systemic therapy response in locally advanced breast cancer patients.
Journal: Clinical imaging
Published: December 30, 2025
Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.
Journal: JCO precision oncology
Published: December 18, 2025
Follow-up after an abnormal screening mammogram: Impact of a pandemic on mobile mammography patients.
Journal: Journal of clinical imaging science
Published: October 02, 2025
Diagnostic Uncertainty & Improving Diagnostic Certainty in Radiology.
Journal: Academic radiology
Published: September 10, 2025
A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease).
Journal: Therapeutic advances in medical oncology
Published: August 28, 2025
Locoregional Nodal Status at Initial Presentation on Ultrasound (US) and Positron Emission Tomography/Computerized Tomography (18F-FDG PET/CT) in Inflammatory Breast Cancer (IBC) Patients is Predictive of Overall Survival.
Journal: Clinical breast cancer
Published: August 22, 2025
Last Updated: 09/26/2026